3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Bipolar Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bockisch, A; Hahn, K; Hiemke, C; Nickel, O; Rao, ML; Schlegel, S; Schlösser, R | 1 |
| Anand, A; Charney, DS; Innis, RB; Seibyl, JP; Seneca, N; Verhoeff, P; Zoghbi, SS | 1 |
2 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Bipolar Disorder
| Article | Year |
|---|---|
[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benperidol; Benzamides; Bipolar Disorder; Brain; Clozapine; Corpus Striatum; Depressive Disorder, Major; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Frontal Lobe; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia, Paranoid; Tomography, Emission-Computed, Single-Photon | 1997 |
Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients.
Topics: Adult; Amphetamine; Benzamides; Bipolar Disorder; Blood Pressure; Brain; Corpus Striatum; Dopamine; Dopamine Antagonists; Female; Heart Rate; Humans; Iodine Radioisotopes; Male; Pulse; Pyrrolidines; Receptors, Dopamine; Tomography, Emission-Computed, Single-Photon | 2000 |